3Calida DM,Constanttmescu C, Purev E, et al. Cutting Edge: C3, a key complement activation,is not required for the development of myelin oligodendroeyte glycoprotein peptide - induced experimental autoimmune encephalomyelitis in mice [J]. J Immunol,2001,166(2) :723 - 726.
4Chen MS,Huber AB, van der Haar ME, et al. Nogo - A is a myelin - associated neurite outgrowth inhibitor and an antigen for monoelonal antibody IN - 1 [J]. Nature, 2000,403 ( 6768 ) :434 - 439.
5Freund P,Sehmidlin E, Wannier T, et al. Nogo - A - specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates [ J ]. Nat Med,2006,12 (7) :790 - 792.
6Ji B, Li M, Wu WT ,et al. LINGO - 1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury[ J]. Mol Cell Neurosci,2006,33(3) :311 -320.
7Niederost B, Oertle T, Fritsche J ,et al. Nogo - A and myelin - associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Racl[J]. J Neurosci,2002,22 ( 23 ) : 10368 - 10376.
8Freund p, Wannier T, Schmidlin E, et al. Anti - Nogo - A antibody treatment enhances sprouting of corticospinal axons rosiral to a unilateral cervical spinal cord lesion in adult macaque monkey [J]. J Comp Neurol, 2007,502 (4):644-659.
9Tsai SY,Markus TM,Andrews EM,et al. Intrathecal treatment with anti - Nogo- A antibody improves functional recovery in adult rats after stroke [J]. Exp Brain Res,2007,182 (2): 261 - 266.
10Mi S, Hu B, Hahm K, et al. LINGO - 1 antagonist promotes spinal cord remyelination and axonal integrity in MOG -induced experimental autoimmune encephalomyelitis[J]. Nat Med,2007,13 (10) : 1228 - 1233.
